Evidence map›Paper›PMID 42583024›Full record

ArticleFrontiers in cardiovascular medicine2026

Synthetic T1 mapping using artificial intelligence and oxygenation-sensitive cardiovascular magnetic resonance for myocardial tissue characterization in hypertrophic cardiomyopathy and cardiac amyloidosis.

Faezeh Lotfikazemi, Mitchel Benovoy, Michael Chetrit, Judy Luu, Leila Haririsanati, Moezedin Javad Rafiee, Matthias G Friedrich

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Faezeh LotfikazemiDepartment of Experimental Medicine, McGill University, Montreal, QC, Canada.
Mitchel BenovoyDepartment of Experimental Medicine, McGill University, Montreal, QC, Canada.
Michael ChetritDivision of Cardiology, McGill University, Montreal, QC, Canada.
Judy LuuDivision of Cardiology, McGill University, Montreal, QC, Canada.
Leila HaririsanatiResearch Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC, Canada.
Moezedin Javad RafieeResearch Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC, Canada.
Matthias G FriedrichDepartment of Experimental Medicine, McGill University, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiovascular magnetic resonance (CMR) techniques provide detailed myocardial tissue characterization. However, LGE requires the administration of contrast agents, while T1/T2 mapping involves prolonged acquisition times, sensitivity to motion artifacts, and protocol complexity. LGE can also be limited in differentiating cardiac amyloidosis from hypertrophic cardiomyopathy (HCM) due to overlapping enhancement patterns. Oxygenation-sensitive CMR (OS-CMR), offers a rapid, contrast-free alternative but lacks direct quantitative outputs. Methods: We propose a unified AI framework integrating DeepOxyMap and a Residual Generative Adversarial Network (R-GAN) to extract latent features and generate synthetic T1 maps from OS-CMR. DeepOxyMap was trained on 117 OS-CMR images using a VGG19-based architecture to identify fibrosis-related myocardial patterns via heatmaps. The R-GAN was subsequently trained on 2,044 OS-CMR images from two independent cohorts to generate T1-parametric maps directly from OS-CMR. Performance was assessed using image similarity metrics, ROI-based clinical validation, T1 recovery curve analysis, and Extended Phase Graph simulations. Results: DeepOxyMap achieved an accuracy of of 83.5%, with a precision of 85.5% and a recall of 79.7%.AUC values were 0.93 (ICMP), 0.88 ( Conclusion: This study demonstrates that OS-CMR contains latent tissue information that can be leveraged to generate quantitative T1 maps using AI. The proposed contrast-free framework enables rapid acquisition, eliminates the need for gadolinium, and preserves clinically relevant myocardial patterns, offering a promising approach for non-invasive cardiac tissue characterization in clinical practice.

Indexed as

artificial intelligencecardiac amyloidosiscardiac MRIgenerative adversarial networkhypertrophic cardiomyopathymyocardial tissue characterizationoxygenation-sensitive cardiovascular magnetic resonancesynthetic T1 mapping

Identifiers

PMID42583024
PMCPMC13459226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.